M&A Deal Summary

Mast Therapeutics Acquires Aires Pharmaceuticals Inc

On February 27, 2014, Mast Therapeutics acquired healthcare services company Aires Pharmaceuticals Inc

Acquisition Highlights
  • This is Mast Therapeutics’ 2nd transaction in the Healthcare Services sector.
  • This is Mast Therapeutics’ 3rd transaction in the United States.
  • This is Mast Therapeutics’ 3rd transaction in California.

M&A Deal Summary
Date 2014-02-27
Target Aires Pharmaceuticals Inc
Sector Healthcare Services
Buyer(s) Mast Therapeutics
Deal Type Add-on Acquisition

Target

Aires Pharmaceuticals Inc

San Diego, California, United States
Aires Pharmaceuticals, Inc operates as a clinical stage pharma company.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mast Therapeutics

San Diego, California, United States
Category Company
Founded 1995
Sector Life Science
Employees28
DESCRIPTION

Mast Therapeutics, Inc.is a bio pharmaceutical company. It is a provider of MAST (Molecular Adhesion and Sealant Technology) platform for clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers to develop MST-188.

DEAL STATS #
Overall 3 of 3
Sector (Healthcare Services) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (California) 3 of 3
Country (United States) 3 of 3
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-11 Synthrx

San Diego, California, United States

Synthrx, Inc. is a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer 188 (188).

Buy -
Mergr

Product

Company

Legal